Zubidox 50 mg Injection

Introduction of Zubidox 50 mg Injection

Zubidox 50 mg Injection is used in combination with other medicines to treat certain types of bladder, breast, lung, stomach, and ovarian cancer, Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (cancer that originates in the cells of the immune system), and certain types of leukaemia (cancer of the white blood cells), including acute lymphocytic leukaemia (ALL) and acute myeloid leukaemia (AML). Zubidox Injection is also used alone and in combination with other drugs to treat certain types of thyroid cancer and certain types of soft tissue or bone sarcoma (cancer that forms in muscles and bones). It is also used to treat neuroblastoma (cancer that starts in nerve cells and occurs mainly in children) and Wilms tumour (a type of kidney cancer that occurs in children). Zubidox 50 mg belongs to a class of drugs called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.

Zubidox 50 should not be used in patients with severe liver disease, severe heart problems, very low blood cell counts caused by prior chemotherapy, or if you recently had a heart attack.

Uses of Zubidox 50 mg Injection

Breast cancer: Zubidox 50 mg Injection is used to treat Breast cancer is a type of cancer that affects the cells in the breast tissue. It is the second most common type of cancer in women and is often characterized by the presence of a tumour or lump in the breast.

Bladder cancer: Zubidox Injection is used in the treatment of Bladder cancer is a type of cancer that affects the bladder, which is a muscular organ in the lower abdomen that stores urine. It is most common in men over the age of 50 and is usually found in the cells lining the inside of the bladder.

Kaposi's sarcoma: Zubidox 50 mg is used in the treatment of Kaposi's sarcoma is a type of cancer that can affect the skin, mouth, and internal organs. It is caused by a virus called human herpesvirus 8 (HHV-8), which is also known as Kaposi's sarcoma-associated herpesvirus (KSHV). Kaposi's sarcoma is more common in people with compromised immune systems, such as people with HIV/AIDS or organ transplant recipients taking immunosuppressive drugs.

Hodgkin's lymphoma: Zubidox 50 is used in the treatment of Hodgkin's lymphoma, also known as Hodgkin's disease, which is a type of cancer that affects the lymphatic system.

Acute lymphocytic leukaemia(ALL): Zubidox 50 mg Injection is used in the treatment of Acute lymphocytic leukaemia a type of cancer that affects the blood and bone marrow.

Benefits of Zubidox 50 mg Injection

Zubidox is a chemotherapy medication that is used to treat a variety of cancers. It works by interfering with the DNA of cancer cells, which can slow their growth and division. Some potential benefits of Zubidox Injection treatment include:

Zubidox 50 may show to be effective in treating a variety of cancers and is often used in combination with other chemotherapy medications.

Side Effects of Zubidox 50 mg Injection

​​​​Zubidox 50 mg Injection may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.​

Most Common Side Effects of Zubidox 50 mg Injection

• Hair loss
• Bone marrow suppression
• Vomiting
• Rash
• Inflammation of the mouth.

Common Side Effects of Zubidox 50 mg Injection

• Allergic reactions such as anaphylaxis
• Heart damage
• Tissue damage at the site of injection
• Radiation recall

How to Use Zubidox 50 mg Injection?

Zubidox Injection is given intravenously (IV), administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of Zubidox 50 will depend on the clinical condition of the patient's age and medical history, and other factors. It is important to follow your doctor's instructions carefully when using this medication. Do not self-administered.​

How Zubidox 50 mg Injection Works?

Zubidox interacts with DNA by inhibition and the intercalation of the macromolecular biosynthesis. Zubidox 50 mg Injectionstabilizes the topoisomerase II complex after it breaks the chain of the DNA needed for replication. Zubidox Injection prevents the double helix DNA to get sealed and it gradually stops the replication process. Zubidox 50 may also increase quinone-type free radical production, hence contributing to its cytotoxicity.

Safety Advices Zubidox 50 mg Injection

Breastfeeding

Unsafe

Liver

Use with Caution

Pregnancy

Unsafe

Kidney

Safe

Driving

Unsafe

Alcohol

Unsafe

References

1. Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, Usp To Its Portfolio Of Off-patent Oncology Products, Pfizer Inc, Available Form 

2. Adriamycin (doxorubicin Hcl) For Injection, Usp, Manufactured, Bedford Laboratories, Product Monograph 

3. Doxorubicin, Cancer Research Uk, Available Form